SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm
Abstract SRSF2 mutations are found in association with JAK2V617F in myeloproliferative neoplasms (MPN), most frequently in myelofibrosis (MF). However, the contribution of SRSF2 mutation in JAK2V617F-driven MPN remains elusive. To investigate the consequences of SRSF2P95H and JAK2V617F mutations in...
Main Authors: | Yue Yang, Salar Abbas, Mohammad A. Sayem, Avik Dutta, Golam Mohi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-11-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-023-00947-y |
Similar Items
-
Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
by: Koki Ueda, et al.
Published: (2017-06-01) -
Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
by: Sabina I. Swierczek, et al.
Published: (2011-05-01) -
Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice
by: Hajime Akada, et al.
Published: (2012-09-01) -
JAK out of the box: myeloproliferative neoplasms--associated JAK2 V617F mutations contribute to aortic aneurysms
by: Shannon Elisabeth Elf
Published: (2021-02-01) -
Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
by: Shunichiro Yasuda, et al.
Published: (2024-04-01)